Strategy | Financing Highlight Private Placement / Financing Transactions TORL BioTherapeutics: The company raised $158 million of Series B venture funding in a deal led by Goldman Sachs Asset Management April 13, 2023. Moore Strategic Ventures and 7 other investors...
Strategy | Financing Highlight Private Placement / Financing Transactions Mercy BioAnalytics: The company raised $41 million of Series A venture funding in a deal led by Novalis LifeSciences on April 3, 2023, putting the company’s pre-money valuation at $81...
Strategy | Financing Highlight Private Placement / Financing Transactions ArriVent Biopharma: The company raised $155 million of Series B venture funding in a deal led by Sofinnova Investments and General Catalyst on March 27, 2023, putting the company’s...
Strategy | Financing Highlight Private Placement / Financing Transactions Flare Therapeutics: The company raised $123 million of Series B venture funding in a deal led by Pfizer Ventures and GordonMD Global Investments on March 22, 2023, putting the company’s...
Strategy | Financing Highlight Private Placement / Financing Transactions Mediar Therapeutics: The company raised $85 million of Series A venture funding in a deal led by Novartis Venture Fund and Sofinnova Partners on March 15, 2023, putting the company’s...
Strategy | Financing Highlight Private Placement / Financing Transactions Bicara Therapeutics: The company raised $108 million of Series B venture funding in a deal led by Red Tree Venture Capital and RA Capital Management on March 6, 2023, putting the...
